GRI BIO, INC. Cash and Cash Equivalents
GRI BIO, INC. (GRI) had Cash and Cash Equivalents of $10.95 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $10.95M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $11.05M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $8.23M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $4.05M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $10.95M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $11.05M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $8.23M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $4.05M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $5.12M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $3.28M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $5.03M 10-K · filed 2026-01-30 | |
| 2024-09-30 | $4.75M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $6.35M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $4.09M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $1.81M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $3.49M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $4.80M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.67M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $9.00K 10-K · filed 2024-03-28 | $3.78M 10-K · filed 2023-02-24 |
| 2022-09-30 | $4.73M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $5.22M 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $2.54M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $3.70M 10-K · filed 2023-02-24 | |
| 2021-09-30 | $5.88M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $10.46M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $12.98M 10-Q · filed 2021-05-13 | |
| 2021-01-11 | $13.00M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $109.00K 10-K · filed 2022-02-14 |